Timothy Myles

Title: Innovations and Contributions of Inventor Timothy Myles

Introduction

Timothy Myles is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of therapeutic antibodies. With a total of four patents to his name, Myles has focused on developing innovative solutions for treating various medical conditions.

Latest Patents

Among his latest patents, Myles has developed therapeutic antibodies against osteopontin. These antibodies are designed to inhibit thrombin-cleavage of osteopontin or block the activity of thrombin cleavage fragments of osteopontin. His work includes antibody conjugates and pharmaceutical compositions that utilize these antibodies, as well as kits that incorporate them. Another significant patent involves monoclonal antibodies against antithrombin beta, which are directed against the human antithrombin beta complexed with heparin. These binding proteins can block the anti-coagulant activity of antithrombin beta, thereby inducing coagulation. The therapeutic uses of these antibodies and methods for screening specific antibodies are also described in his patent documents.

Career Highlights

Timothy Myles has worked with prominent organizations such as Bayer Healthcare LLC and Leland Stanford Junior University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical therapies.

Collaborations

Some of his notable coworkers include Ye Jin and John E Murphy, who have collaborated with him on various projects related to his patents and research.

Conclusion

Timothy Myles is a distinguished inventor whose work in therapeutic antibodies has the potential to impact the treatment of osteopontin-associated disorders and coagulation issues. His innovative contributions continue to advance the field of medical research and therapy.